Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by skier59on Nov 10, 2020 1:25pm
80 Views
Post# 31871106

RE:RE:RE:RE:RE:RE:RE:Aristotle

RE:RE:RE:RE:RE:RE:RE:Aristotle I think it should be launched ASAP, even without a Marketing Campaign. Start from the First Patient, and stop being a Zero! COVID will carry us nicely until the right time, but Aristotle HAS to be released 2020.




justintime1990 wrote: In my opinion, we've waited a long time for Aristotle, so what's a little while longer? A launch right now would be lost in all the COVID and political turmoil, it's best to wait until things settle on both fronts. COVID testing is a cash cow that Stage should take advantage of everyway they can in terms of revenue, building relationships, proving themselves a worthy and dependable partner. If Stage proves they can consistently deliver on accurate and on time testing, partners will grow and the word will spread. Right now it's come for COVID, stay for cancer. COVID will be a revenue stream that generates income for months to come and puts us in a strong financial situation for the future. I'm willing to wait on the right timing for Aristotle knowing covid is tying us over in revenue for the time being. Timing is everything, and I think the best timing would be towards the tail end of the pandemic when things are slowly transitioning back to normal. The only downside is that this technology is not put to work testing for cancers sooner. I'll stay patient, the future is bright. 


Bullboard Posts